Discover how groundbreaking research on unique immune cells and advanced AI tools offers renewed hope for improving cancer ...

Dana-Farber researchers identified factors predicting the success of donor lymphocyte infusion (DLI) in treating relapsed AML ...

B-cell prolymphocytic leukemia (B-PLL) is a rare, aggressive type of leukemia that progresses rapidly. People with B-PLL typically have a less favorable outlook. However, new targeted treatments ...

New Drug Tested to Reduce Side Effect of 'Half-Matched' Stem Cell Transplants Dec. 5, 2024 — Stem cell transplantation is used to treat several types of blood cancers, but carries the risk of a ...

Researchers have identified key factors that determine the success of leukemia cell therapies, including DLI, in achieving ...

A research team made a pivotal discovery in the field of cancer immunotherapy. The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed ...